Earnings History
EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.05%
Next Report
Sep 03, 2026
Period
EPS Actual
EPS Est
Surprise
March 31, 2026
$-0.06
$-0.06
0.00%
Dec. 31, 2025
$-0.09
$-0.08
-0.01%
Sept. 30, 2025
$-0.11
$-0.10
-0.01%
June 30, 2025
$-0.49
$-0.37
-0.12%
March 31, 2025
$-0.49
$-0.37
-0.12%
Peer comparison (GICS sub-industry)
Key metrics vs sector peers
Ticker
Market Cap
P/E
Rev YoY
Net Margin
ROE
Gross Margin
IBIO
$15M
-0.4
77.8%
-4594.2%
-101.5%
—
FRMM
—
—
—
-6881.3%
-368.1%
—
ANVS
$94M
-2.5
—
—
-164.0%
—
CYPH
$97M
16.6
—
—
6.1%
—
NMAD
—
—
—
—
—
—
RNTX
—
-0.6
—
—
—
—
DWTX
$124M
-0.6
123.6%
—
-83.8%
—
CRDF
$192M
-4.1
-13.2%
-7732.0%
-88.2%
—
SPRO
$131M
15.5
39.2%
12.8%
18.7%
—
GOSS
$724M
-4.1
-57.7%
-351.5%
201.8%
—
Full Fundamentals
All metrics by year — income statement, balance sheet, cash flow
Income Statement17
Annual Income Statement data for IBIO
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue
$400.0K
$225.0K
$0
$2M
$2M
$2M
$2M
$444.0K
$394.0K
$948.0K
$2M
$205.0K
Cost of Revenue
·
·
·
$216.0K
$1M
$703.0K
·
·
·
·
·
·
Gross Profit
·
·
·
$2M
$909.0K
$935.0K
·
·
·
·
·
·
R&D Expense
$8M
$5M
$10M
$10M
$10M
$4M
$5M
$4M
$4M
$3M
$3M
$2M
SG&A Expense
$11M
$12M
$19M
$22M
$22M
$11M
$12M
$11M
$11M
$8M
$5M
$4M
Operating Expenses
$19M
$17M
$29M
$32M
$32M
$15M
$18M
$15M
$15M
$11M
$9M
$4M
Operating Income
$-19M
$-17M
$-29M
$-30M
$-31M
$-14M
$-16M
$-14M
$-14M
$-10M
$-7M
$-4M
Interest Expense
·
·
$83.0K
$1M
$2M
$2M
$2M
$2M
$2M
$807.0K
$0
$0
Interest Income
$437.0K
$363.0K
$213.0K
$177.0K
$140.0K
$15.0K
$75.0K
$15.0K
$39.0K
$22.0K
$9.0K
$8.0K
Other Non-op
$225.0K
$1M
$32.0K
$184.0K
$8M
$-2M
$-2M
$-2M
$-2M
$-764.0K
$41.0K
$3.0K
Income Tax
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Net Income
$-18M
$-25M
$-65M
$-50M
$-23M
$-16M
$-18M
$-16M
$-15M
$-10M
$-7M
$-4M
EPS (Basic)
$-1.75
$-6.50
$-106.19
$-5.78
$-3.00
·
·
·
·
·
·
·
EPS (Diluted)
$-1.75
$-6.50
$-106.19
$-5.78
$-3.00
·
·
·
·
·
·
·
Shares (Basic)
10,499,000
3,831,000
612,000
8,721,000
7,825,000
·
·
·
·
·
·
·
Shares (Diluted)
10,499,000
3,831,000
612,000
8,721,000
7,825,000
·
·
·
·
·
·
·
EBITDA
$-19M
$-17M
$-29M
$-50M
$-31M
·
$-16M
$-14M
$-14M
$-10M
$-7M
·
Balance Sheet24
Annual Balance Sheet data for IBIO
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Cash & Equivalents
$9M
$14M
$4M
$23M
$77M
$55M
$4M
$4M
$16M
$16M
$9M
$4M
Receivables
·
$0
$0
$1M
$426.0K
$75.0K
$97.0K
$75.0K
$175.0K
$484.0K
$445.0K
$205.0K
Inventory
·
$0
$0
$4M
$27.0K
·
·
·
·
·
·
·
Prepaid Expense
$1M
$749.0K
$664.0K
$2M
$2M
$214.0K
$290.0K
$276.0K
$283.0K
$264.0K
$182.0K
$118.0K
Other Current Assets
·
·
·
·
·
·
·
·
·
·
$17.0K
$8.0K
Current Assets
$10M
$16M
$26M
$45M
$105M
$62M
$5M
$16M
$9M
$24M
$10M
$4M
PP&E (Net)
$3M
$4M
$4M
$1M
$9M
$4M
$24M
$25M
$26M
$26M
$13.0K
$6.0K
PP&E (Gross)
$5M
$5M
$5M
$1M
$10M
$4M
$29M
$28M
$27M
$26M
$40.0K
·
Accum. Depreciation
$1M
$1M
$400.0K
$0
$1M
$753.0K
$5M
$3M
$2M
$605.0K
$27.0K
·
Intangibles
$7M
$5M
$5M
$5M
$952.0K
$1M
$1M
$2M
$2M
$2M
$2M
$3M
Total Assets
$23M
$29M
$41M
$99M
$147M
$94M
$31M
$43M
$36M
$52M
$12M
$6M
Accounts Payable
$2M
$358.0K
$2M
$4M
$2M
$2M
$1M
$790.0K
$749.0K
$1M
$1M
$297.0K
Accrued Liabilities
$1M
$2M
$5M
$4M
$3M
$1M
$965.0K
$1M
$924.0K
$920.0K
$159.0K
$98.0K
Short-term Debt
$766.0K
$218.0K
$13M
$22M
$600.0K
$261.0K
$0
·
·
·
·
·
Current Liabilities
$6M
$4M
$22M
$30M
$7M
$5M
$3M
$2M
$2M
$2M
$1M
$395.0K
Capital Leases
$2M
$3M
$3M
$4M
$0
$0
$25M
$25M
$25M
$25M
$0
·
Total Liabilities
$8M
$7M
$26M
$36M
$38M
$38M
$28M
$27M
$27M
$28M
$1M
$395.0K
Total Debt
$766.0K
$218.0K
$13M
$22M
$600.0K
·
·
·
·
·
·
·
Common Stock
$19.0K
$9.0K
$1.0K
$9.0K
$9.0K
$140.0K
$20.0K
$16.0K
$9.0K
$89.0K
$77.0K
$66.0K
Retained Earnings
$-332M
$-314M
$-289M
$-224M
$-174M
$-150M
$-106M
$-88M
$-72M
$-58M
$-48M
$-41M
AOCI
·
·
·
$-213.0K
$-63.0K
$-33.0K
$-31.0K
$-30.0K
$-29.0K
$-29.0K
$-25.0K
$0
Stockholders' Equity
$15M
$21M
$15M
$63M
$109M
$57M
$2M
$16M
$9M
$10M
$11M
$6M
Liabilities + Equity
$23M
$29M
$41M
$99M
$147M
$94M
$31M
$43M
$36M
$52M
$12M
$6M
Shares Outstanding
19,349,201
8,623,676
1,015,505
8,727,158
8,714,924
140,071,110
20,152,458
16,040,126
8,911,851
89,109,410
77,205,410
65,642,095
Cash Flow12
Annual Cash Flow data for IBIO
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
D&A
·
·
·
·
·
·
$179.0K
·
·
·
·
·
Stock-based Comp
$2M
$2M
$4M
$4M
$2M
$388.0K
$241.0K
$770.0K
$1M
$1M
$914.0K
$1M
Deferred Tax
$-9M
$-5M
$-13M
·
·
·
·
·
·
·
·
·
Amort. of Intangibles
$20.0K
$20.0K
$126.0K
$401.0K
$291.0K
$298.0K
$322.0K
$341.0K
$350.0K
$363.0K
$358.0K
$358.0K
Operating Cash Flow
$-15M
$-19M
$-30M
$-37M
$-30M
$-13M
$-14M
$-13M
$-13M
$-8M
$-5M
$-4M
CapEx
$16.0K
$210.0K
$6M
$7M
$5M
$1M
$920.0K
$934.0K
$1M
$68.0K
$13.0K
$4.0K
Investing Cash Flow
$742.0K
$906.0K
$7M
$-5M
$-26M
$-1M
$-990.0K
$-1M
$-2M
·
·
·
Stock Issued
$4M
$26M
$11M
·
·
·
·
·
$0
$6M
$10M
$480.0K
Net Stock Activity
$4M
$26M
·
·
·
·
·
·
$0
$6M
$10M
·
Financing Cash Flow
$9M
$24M
$2M
$-6M
$79M
$65M
$3M
$22M
$-170.0K
·
·
·
Net Change in Cash
$-6M
$7M
$-21M
$-49M
$22M
$51M
$-12M
$8M
$-15M
$14M
$6M
$-824.0K
Free Cash Flow
$-15M
$-19M
$-36M
$-45M
$-35M
·
$-15M
$-14M
$-14M
$-8M
$-5M
·
Profitability6
Annual Profitability data for IBIO
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Gross Margin
·
·
·
90.9%
38.3%
·
·
·
·
·
·
·
Operating Margin
-4650.5%
-7392.9%
·
-2085.2%
-1312.1%
·
-782.4%
-3204.3%
-3622.8%
-1043.6%
-360.1%
·
Net Margin
-4594.2%
-11069.8%
·
-2110.9%
-978.8%
·
-871.8%
-3627.2%
-3688.3%
-1030.0%
-357.9%
·
EBITDA Margin
-4650.5%
-7392.9%
·
-2085.2%
-1312.1%
·
-782.4%
-3204.3%
-3622.8%
-1043.6%
-360.1%
·
ROA
-70.8%
-71.2%
-92.5%
-40.8%
-16.0%
·
-53.1%
-43.5%
-37.9%
-19.1%
-69.8%
·
ROE
-101.5%
-135.7%
-164.9%
-58.5%
-28.1%
·
-188.9%
-128.4%
-154.2%
-92.2%
-76.5%
·
Liquidity & Solvency4
Annual Liquidity & Solvency data for IBIO
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Current Ratio
1.6
4.1
1.2
1.5
15.7
·
1.4
8.0
4.3
10.4
·
·
Quick Ratio
1.4
3.7
0.2
0.8
11.7
·
1.3
7.9
4.1
10.3
·
·
Debt / Equity
0.1
0.0
0.8
0.3
0.0
·
·
·
·
·
·
·
Interest Coverage
·
·
-353.5
-35.2
-12.7
·
-8.3
-7.4
-7.4
-12.3
·
·
Efficiency3
Annual Efficiency data for IBIO
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Asset Turnover
0.0
0.0
0.0
0.0
0.0
·
0.1
0.0
0.0
0.0
0.2
·
Inventory Turnover
·
·
·
0.1
·
·
·
·
·
·
·
·
Receivables Turnover
·
·
·
3.3
9.5
·
23.5
3.6
1.2
2.0
5.7
·
Per Share5
Annual Per Share data for IBIO
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Book Value / Share
$0.77
$2.47
$0.76
$7.27
$0.50
·
$0.12
$1.01
$0.10
$0.11
$0.15
·
Revenue / Share
$0.04
$0.06
$0.00
$0.27
·
·
·
·
·
·
·
·
Cash Flow / Share
$-1.46
$-4.84
$-2.49
$-4.30
·
·
·
·
·
·
·
·
Cash / Share
$0.44
$1.65
$0.21
$2.60
$0.36
·
$0.22
$0.99
$0.09
$0.26
$0.12
·
EPS (TTM)
$-1.75
$-6.50
$-106.19
$-5.78
$-3.00
·
·
·
·
·
·
·
Growth Rates3
Annual Growth Rates data for IBIO
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue YoY
77.8%
·
·
-20.5%
44.8%
·
·
·
·
·
·
·
Revenue CAGR 3Y
-40.3%
-54.4%
·
·
·
·
·
·
·
·
·
·
Revenue CAGR 5Y
-24.6%
·
·
·
·
·
·
·
·
·
·
·
Valuation (TTM)14
Annual Valuation (TTM) data for IBIO
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue TTM
$400.0K
$225.0K
$0
$2M
$2M
$2M
$2M
$444.0K
$394.0K
$948.0K
$2M
$205.0K
Net Income TTM
$-18M
$-25M
$-65M
$-50M
$-23M
$-16M
$-18M
$-16M
$-15M
$-10M
$-7M
$-4M
Market Cap
$15M
$18M
$248M
$1.13B
$164.49B
·
$7.15B
$7.22B
$173.78B
$320.79B
$366.73B
·
Enterprise Value
$7M
$4M
$256M
$1.13B
$164.42B
·
·
·
·
·
·
·
P/E
-0.4
-0.3
-0.1
-22.5
-251.7
·
·
·
·
·
·
·
P/S
36.8
80.9
·
602.2
69377.6
·
3545.2
16256.9
441068.8
338390.2
198123.0
·
P/B
1.0
0.9
16.1
17.9
1514.9
·
2904.6
446.5
19495.3
32282.8
32653.0
·
P / Tangible Book
1.8
1.1
24.8
19.3
1528.3
2802.7
·
·
·
·
·
·
P / Cash Flow
-1.0
-1.0
-8.1
-30.3
-5471.5
·
-511.9
-535.5
-13202.2
-39741.6
-77613.9
·
P / FCF
-1.0
-1.0
-6.8
-25.3
-4702.0
·
-480.3
-500.8
-11996.5
-39409.6
-77400.9
·
EV / EBITDA
-0.4
-0.3
-8.7
-22.8
-5284.9
·
·
·
·
·
·
·
EV / FCF
-0.4
-0.2
-7.1
-25.3
-4699.8
·
·
·
·
·
·
·
EV / Revenue
17.2
18.7
·
601.9
69345.2
·
·
·
·
·
·
·
Earnings Yield
-230.3%
-308.1%
-870.4%
-4.5%
-0.40%
·
·
·
·
·
·
·
Income Statement15
Quarterly Income Statement data for IBIO
Metric
Trend
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Revenue
$0
$0
$100.0K
$200.0K
$0
$200.0K
$0
$175.0K
$0
$0
$50.0K
$0
$0
$0
$0
$0
R&D Expense
$3M
$4M
$4M
$3M
$2M
$2M
$1M
$1M
$904.0K
$2M
$2M
$2M
$3M
$3M
$3M
$4M
SG&A Expense
$5M
$5M
$3M
$2M
$3M
$3M
$3M
$2M
$3M
$3M
$4M
$3M
$4M
$8M
$5M
$7M
Operating Expenses
$8M
$9M
$6M
$5M
$5M
$5M
$4M
$4M
$4M
$4M
$5M
$5M
$6M
$11M
$8M
$10M
Operating Income
$-8M
$-9M
$-6M
$-5M
$-5M
$-4M
$-4M
$-3M
$-4M
$-4M
$-5M
$-5M
$-6M
$-11M
$-8M
$-10M
Interest Expense
·
·
·
·
·
·
·
·
$52.0K
$34.0K
$26.0K
·
$35.0K
$31.0K
·
·
Interest Income
$657.0K
$493.0K
$267.0K
$79.0K
$72.0K
$112.0K
$174.0K
$223.0K
$43.0K
$42.0K
$55.0K
$50.0K
$23.0K
$41.0K
$99.0K
$66.0K
Other Non-op
$635.0K
$452.0K
$231.0K
$35.0K
$18.0K
$55.0K
$117.0K
$163.0K
$991.0K
$8.0K
$29.0K
$33.0K
$-110.0K
$10.0K
$99.0K
$68.0K
Income Tax
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Net Income
$-8M
$-9M
$-6M
$-5M
$-5M
$-4M
$-4M
$-8M
$-3M
$-8M
$-6M
$-6M
$-7M
$-34M
$-18M
$-17M
EPS (Basic)
$-0.06
$-0.09
$-0.11
$-0.32
$-0.49
$-0.48
$-0.46
$3.57
$-0.85
$-4.42
$-4.80
$-24.64
$-11.07
$-68.43
$-2.05
$-1.96
EPS (Diluted)
$-0.06
$-0.09
$-0.11
$-0.32
$-0.49
$-0.48
$-0.46
$3.57
$-0.85
$-4.42
$-4.80
$-24.64
$-11.07
$-68.43
$-2.05
$-0.59
Shares (Basic)
119,600,000
99,133,000
52,981,000
-17,128,000
9,862,000
9,132,000
8,633,000
-2,936,000
3,713,000
1,856,000
1,198,000
-9,379,000
659,000
490,000
8,842,000
-17,428,000
Shares (Diluted)
119,600,000
99,133,000
52,981,000
-17,128,000
9,862,000
9,132,000
8,633,000
-2,936,000
3,713,000
1,856,000
1,198,000
-9,379,000
659,000
490,000
8,842,000
-17,428,000
EBITDA
$-8M
$-9M
$-6M
·
$-5M
$-4M
$-4M
·
$-4M
$-4M
$-5M
·
$-6M
$-11M
$-8M
·
Balance Sheet23
Quarterly Balance Sheet data for IBIO
Metric
Trend
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Cash & Equivalents
$48M
$29M
$28M
$9M
$5M
$7M
$11M
$14M
$5M
$3M
$1M
$4M
$7M
$4M
$10M
$23M
Receivables
·
·
$65.0K
·
·
·
·
·
·
·
$0
·
$70.0K
$970.0K
$1M
$1M
Inventory
·
·
·
·
·
·
·
·
$0
$0
$0
$0
·
·
·
$4M
Prepaid Expense
$2M
$670.0K
$1M
$1M
$1M
$1M
$667.0K
$749.0K
$862.0K
$894.0K
$451.0K
$664.0K
$921.0K
$414.0K
$1M
$2M
Current Assets
$77M
$53M
$51M
$10M
$6M
$8M
$12M
$16M
$36M
$20M
$23M
$26M
$27M
$38M
$64M
$45M
PP&E (Net)
$3M
$3M
$3M
$3M
$3M
$3M
$4M
$4M
$4M
$4M
$4M
$4M
$4M
$4M
$3M
$1M
PP&E (Gross)
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$4M
·
$1M
Accum. Depreciation
$2M
$2M
$2M
$1M
$1M
$1M
$1M
$1M
$893.0K
$729.0K
$565.0K
$400.0K
$235.0K
$115.0K
·
$0
Intangibles
$2M
$4M
$7M
$7M
$6M
$6M
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$5M
$6M
$5M
Total Assets
$86M
$64M
$64M
$23M
$19M
$22M
$25M
$29M
$50M
$34M
$38M
$41M
$44M
$52M
$85M
$99M
Accounts Payable
$3M
$3M
$3M
$2M
$1M
$614.0K
$855.0K
$358.0K
$1M
$2M
$2M
$2M
$2M
$4M
$5M
$4M
Accrued Liabilities
$2M
$2M
$850.0K
$1M
$1M
$2M
$1M
$2M
$4M
$4M
$3M
$5M
$4M
$5M
$3M
$4M
Short-term Debt
·
·
$706.0K
$766.0K
$824.0K
$237.0K
$227.0K
$218.0K
$13M
$13M
$13M
·
$14M
$16M
$22M
$22M
Current Liabilities
$7M
$6M
$6M
$6M
$5M
$5M
$3M
$4M
$21M
$22M
$21M
$22M
$22M
$28M
$32M
$30M
Capital Leases
$2M
$2M
$2M
$2M
$2M
$2M
$3M
$3M
$3M
$3M
$3M
$3M
$3M
$3M
$3M
$4M
Total Liabilities
$8M
$8M
$8M
$8M
$8M
$8M
$7M
$7M
$25M
$25M
$24M
$26M
$27M
$33M
$36M
$36M
Total Debt
·
·
$706.0K
·
$824.0K
$237.0K
$227.0K
·
$13M
$13M
$13M
·
$14M
$16M
$22M
·
Common Stock
$35.0K
$30.0K
$20.0K
$19.0K
$10.0K
$9.0K
$9.0K
$9.0K
$9.0K
$30.0K
$28.0K
$1.0K
$16.0K
$12.0K
$9.0K
$9.0K
Retained Earnings
$-355M
$-347M
$-338M
$-332M
$-327M
$-322M
$-318M
$-314M
$-306M
$-303M
$-295M
$-289M
$-283M
$-276M
$-242M
$-224M
AOCI
$-21.0K
$10.0K
$-15.0K
·
·
·
·
·
·
·
·
·
·
$-167.0K
$-223.0K
$-213.0K
Stockholders' Equity
$78M
$57M
$56M
$15M
$11M
$14M
$18M
$21M
$25M
$9M
$13M
$15M
$17M
$19M
$48M
$63M
Liabilities + Equity
$86M
$64M
$64M
$23M
$19M
$22M
$25M
$29M
$50M
$34M
$38M
$41M
$44M
$52M
$85M
$99M
Shares Outstanding
34,543,561
30,053,070
20,254,599
19,349,201
10,066,276
9,167,670
8,637,895
8,623,676
8,517,449
3,243,725
27,653,582
1,015,505
12,368,287
12,368,287
9,006,582
8,727,158
Cash Flow10
Quarterly Cash Flow data for IBIO
Metric
Trend
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Stock-based Comp
$377.0K
$253.0K
$323.0K
$270.0K
$370.0K
$475.0K
$415.0K
$360.0K
$457.0K
$456.0K
$765.0K
$446.0K
$2M
$1M
$1M
$1M
Amort. of Intangibles
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$5.0K
$49.0K
$67.0K
$68.0K
Operating Cash Flow
$-6M
$-5M
$-6M
$-5M
$-3M
$-4M
$-4M
$-5M
$-4M
$-5M
$-5M
$-5M
$-4M
$-8M
$-14M
$-12M
CapEx
$11.0K
$516.0K
$32.0K
$1.0K
$14.0K
$1.0K
$0
$210.0K
$0
·
·
$506.0K
$-201.0K
$3M
$2M
$3M
Investing Cash Flow
$-3M
$-3M
$-21M
$45.0K
$-14.0K
$-2.0K
$713.0K
$-144.0K
$1M
$0
$50.0K
$-6.0K
$8M
$-1M
$29.0K
$477.0K
Stock Issued
$3M
$0
$219.0K
$2M
$1M
$0
$4.0K
$14M
$4M
$4M
$3M
·
·
·
·
·
Net Stock Activity
·
·
$219.0K
·
·
·
$4.0K
·
·
·
·
·
·
·
·
·
Financing Cash Flow
$28M
$9M
$47M
$8M
$1M
$-152.0K
$-162.0K
$13M
$5M
$4M
$2M
$3M
$1M
$-3M
$1M
$-10.0K
Net Change in Cash
$19M
$561.0K
$20M
$4M
$-2M
$-4M
$-3M
$8M
$2M
$-701.0K
$-3M
$-2M
$6M
$-12M
$-13M
$-11M
Free Cash Flow
·
·
$-6M
·
·
·
·
·
·
·
·
·
·
·
$-16M
·
Profitability5
Quarterly Profitability data for IBIO
Metric
Trend
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Operating Margin
·
·
-5951.0%
·
·
-2209.5%
·
·
·
·
-10206.0%
·
·
·
·
·
Net Margin
·
·
-5720.0%
·
·
-2182.0%
·
·
·
·
-11492.0%
·
·
·
·
·
EBITDA Margin
·
·
-5951.0%
·
·
-2209.5%
·
·
·
·
-10206.0%
·
·
·
·
·
ROA
-14.7%
-20.9%
-12.9%
·
-14.0%
-15.7%
-12.8%
·
-6.7%
-19.1%
-9.4%
·
-9.1%
-37.6%
-15.9%
·
ROE
-17.4%
-25.5%
-15.5%
·
-26.8%
-37.8%
-25.8%
·
-15.0%
-58.6%
-18.7%
·
-15.1%
-61.3%
-24.3%
·
Liquidity & Solvency4
Quarterly Liquidity & Solvency data for IBIO
Metric
Trend
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Current Ratio
11.9
9.0
8.4
·
1.1
1.8
3.4
·
1.7
0.9
1.1
·
1.2
1.4
2.0
·
Quick Ratio
7.3
4.9
4.7
·
0.9
1.5
3.2
·
0.2
0.1
0.1
·
0.3
0.2
0.3
·
Debt / Equity
·
·
0.0
·
0.1
0.0
0.0
·
0.5
1.4
1.0
·
0.8
0.9
0.5
·
Interest Coverage
·
·
·
·
·
·
·
·
-69.7
-132.2
-196.3
·
-176.3
-341.1
·
·
Efficiency2
Quarterly Efficiency data for IBIO
Metric
Trend
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Asset Turnover
·
0.0
0.0
·
0.0
0.0
0.0
·
·
·
0.0
·
0.0
0.0
0.0
·
Receivables Turnover
·
·
3.1
·
·
·
·
·
·
·
0.1
·
0.0
0.0
0.0
·
Per Share5
Quarterly Per Share data for IBIO
Metric
Trend
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Book Value / Share
$2.24
$1.88
$2.77
·
$1.13
$1.52
$2.06
·
$2.92
$2.84
$0.48
·
$1.41
$1.52
$5.37
·
Revenue / Share
·
$0.00
$0.00
·
$0.00
$0.02
$0.00
·
·
·
$0.00
·
$0.00
$0.00
$0.00
·
Cash Flow / Share
·
·
$-0.11
·
·
·
$-0.43
·
·
·
$-0.22
·
·
·
$-1.58
·
Cash / Share
$1.38
$0.95
$1.39
·
$0.49
$0.77
$1.28
·
$0.62
$0.86
$0.05
·
$0.53
$0.30
$1.10
·
EPS (TTM)
$-0.75
$-1.17
$-1.54
·
$-2.28
$-6.21
$-10.53
·
$-21.14
$-88.72
$-86.35
·
$-82.97
$-73.27
$-7.24
·
Valuation (TTM)14
Quarterly Valuation (TTM) data for IBIO
Metric
Trend
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Revenue TTM
$300.0K
$300.0K
$300.0K
·
·
·
·
·
$50.0K
$50.0K
$50.0K
·
$2M
$2M
$2M
·
Net Income TTM
$-27M
$-24M
$-19M
·
$-16M
$-20M
$-21M
·
$-24M
$-55M
$-65M
·
$-71M
$-76M
$-51M
·
Market Cap
$66M
$58M
$17M
·
$40M
$22M
$19M
·
$35M
$4M
$166M
·
$515M
$109M
$766M
·
Enterprise Value
·
·
$-11M
·
$36M
$16M
$8M
·
$42M
$14M
$177M
·
$522M
$121M
$778M
·
P/E
-2.5
-1.6
-0.5
·
-1.8
-0.4
-0.2
·
-0.2
-0.0
-0.1
·
-0.5
-0.1
-11.7
·
P/S
218.8
193.3
56.0
·
·
·
·
·
691.6
88.9
3318.4
·
285.8
60.5
406.3
·
P/B
0.8
1.0
0.3
·
3.6
1.6
1.1
·
1.4
0.5
12.6
·
29.6
5.8
15.8
·
P / Tangible Book
0.9
1.1
0.3
·
7.7
2.9
1.5
·
1.8
1.2
21.2
·
42.9
8.1
18.1
·
P / Cash Flow
·
·
-3.0
·
·
·
-5.2
·
·
·
-31.1
·
·
·
-54.8
·
P / FCF
·
·
-3.0
·
·
·
·
·
·
·
·
·
·
·
-46.6
·
EV / EBITDA
·
·
1.8
·
-7.4
-3.5
-2.0
·
-11.6
-3.2
-34.7
·
-84.6
-11.5
-101.9
·
EV / FCF
·
·
1.9
·
·
·
·
·
·
·
·
·
·
·
-47.3
·
EV / Revenue
·
·
-35.3
·
·
·
·
·
838.7
286.2
3541.7
·
289.8
67.3
412.9
·
Earnings Yield
-39.5%
-60.6%
-185.5%
·
-56.7%
-253.5%
-474.3%
·
-520.7%
-6475.9%
-1439.2%
·
-199.4%
-832.6%
-8.5%
·
Financial Statements
Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
2025-06-30
2024-06-30
2023-06-30
2022-06-30
2021-06-30
Revenue
$400.0K
$225.0K
$0
$2M
$2M
Gross Margin %
—
—
—
90.9%
38.3%
Operating Margin %
-4650.5%
-7392.9%
—
-2085.2%
-1312.1%
Net Income
$-18M
$-25M
$-65M
$-50M
$-23M
Diluted EPS
$-1.75
$-6.50
$-106.19
$-5.78
$-3.00
Balance Sheet
2025-06-30
2024-06-30
2023-06-30
2022-06-30
2021-06-30
Debt / Equity
0.1
0.0
0.8
0.3
0.0
Current Ratio
1.6
4.1
1.2
1.5
15.7
Quick Ratio
1.4
3.7
0.2
0.8
11.7
Cash Flow
2025-06-30
2024-06-30
2023-06-30
2022-06-30
2021-06-30
Free Cash Flow
$-15M
$-19M
$-36M
$-45M
$-35M
My Metrics
Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F)
60 filers · $59.4M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
New positions
Exited positions
Increased
Decreased
Net shares change
19
(+6 vs prior Q)
12
(+1 vs prior Q)
18
(+4 vs prior Q)
9
(+1 vs prior Q)
+16.7M
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners
5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
Filer
Filed
Stake
Status
Purpose
Filing
EASTERN CAPITAL LIMITED, PORTFOLIO SERVICES LTD., KENNETH B. DART
×18 filings
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership
Held by 3 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.